acut pulmonari effect aerosol pentamidin studi toronto aerosol pentamidin studi tap group june februari patient human immunodefici viru random double-blind placebo-control trial efficaci toxic aerosol pentamidin AP secondari prophylaxi pneumocysti carinii pneumonia patient underw spirometr evalu treatment signific differ result baselin pulmonari function test group eleven patient percent AP group cough signific reduct forc expiratori flow rate AP patient percent placebo group cough signific chang expiratori flow rate bronchospast episod self-limit inhal albuterol salbutamol treatment AP treatment attack percent actual incid bronchospasm spirometri percent mild 